ROUND TABLE DISCUSSIONS FROM CHICAGO 2017

     
     

 


VIDEO UPDATES FROM CHICAGO 2017

     
     
     
     
     
     
     
     
     
     
     
     
     
     
     

DATA WATCH 

Our expert faculty members have identified key abstracts to watch during the upcoming conference in Chicago 2017.

Breast data watch GI data watch Lung data watch
GU data watch Melanoma data watch  

 

Member Comments. (0)

Oncology Clinical News

Bristol-Myers Kidney Cancer Drug Fails Late-stage Trial

(Reuters) Aug 15, 2017 - Bristol-Myers Squibb Co said on Tuesday its combination drug to treat previously untreated patients with advanced or metastatic renal cell carcinoma, a type of kidney cancer, failed to meet one of the main goals of a late-stage trial.
Read full article.

FDA Accepts Supplemental Biologics License Application and Grants Priority Review for ADCETRIS® (Brentuximab Vedotin) in Cutaneous T-Cell Lymphoma

(Yahoo! Finance) Aug 16, 2017 - Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental Biologics License Application (BLA) based on data from the phase 3 ALCANZA trial and two phase 2 investigator-sponsored trials of ADCETRIS (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL).
Read full article.

Powered by OBR Oncology